Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.65 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.65 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.38 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.38 |
| ▸ | F11 | P03951 | 1/20 | 0.38 |
| ▸ | TERF2IP | Q9NYB0 | 2/20 | 0.38 |
| ▸ | NPY1R | P25929 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 1/20 | 0.37 |
| ▸ | NPY4R | P50391 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.36 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.36 |
| ▸ | PRKAR2A | P13861 | 7/20 | 0.36 |
| ▸ | PRKAR2B | P31323 | 5/20 | 0.36 |
| ▸ | TSLP | Q969D9 | 1/20 | 0.35 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.35 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26181836 | 0.98 | KDM1A (0.68) | KDM1ARCOR1TEAD4TEAD3F11 | |
| SCHEMBL26181847 | 0.97 | KDM1A (0.67) | KDM1ARCOR1F11TERF2IPSSTR2 | |
| SCHEMBL25582800 | 0.96 | KDM1A (0.64) | KDM1ARCOR1F11TERF2IPNPY1R | |
| SCHEMBL25582813 | 0.96 | KDM1A (0.65) | KDM1ARCOR1TEAD4TEAD3F11 | |
| SCHEMBL25582804 | 0.94 | KDM1A (0.66) | KDM1ARCOR1TEAD4TEAD3F11 | |
| SCHEMBL25582809 | 0.94 | KDM1A (0.67) | KDM1ARCOR1TEAD4TEAD3F11 | |
| SCHEMBL25582811 | 0.91 | KDM1A (0.61) | KDM1ARCOR1TEAD4TEAD3TERF2IP | |
| SCHEMBL25582795 | 0.90 | KDM1A (0.62) | KDM1ARCOR1TERF2IPNPY1RNPY2R | |
| SCHEMBL25582796 | 0.88 | KDM1A (0.58) | KDM1ARCOR1TERF2IPNPY1RNPY2R | |
| SCHEMBL26181706 | 0.85 | KDM1A (0.78) | KDM1ARCOR1TERF2IPSSTR2SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190950-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190950-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | FCGR3B, FCGR1A, FCGR2A | KDM1A 4789/4885RCOR1 4863/4885TEAD4 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.